title: Macrophage colony-stimulating factor produced by diffuse large B-cell lymphoma.
authors.affiliation: Department of Internal Medicine, 2-7 Daigakumachi, Takatsuki City, Osaka 569-0801, Japan. in1304@poh.osaka-med.ac.jp
authors.forename: Shoko
authors.initials: S
authors.lastname: Nakayama-Ichiyama
authors.forename: Taiji
authors.initials: T
authors.lastname: Yokote
authors.forename: Satoko
authors.initials: S
authors.lastname: Oka
authors.forename: Takayuki
authors.initials: T
authors.lastname: Takubo
authors.forename: Motomu
authors.initials: M
authors.lastname: Tsuji
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Hanafusa
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D016173:Macrophage Colony-Stimulating Factor / Q000096:biosynthesis*; D008297:Male; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D011239:Prednisolone / Q000627:therapeutic use; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D009363:Neoplasm Proteins; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D016173:Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide; D011239:Prednisolone